Skip to main content
High RiskFDAfda-F-1467-2017UNDECLARED ALLERGEN

Market District Wasabi Soybeans; Net Wt. 6 OZ.; Best By 3/6/17

Category
Units Affected
432
Recall Date
September 29, 2016
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1467-2017.

Undeclared Wheat and Soy Allergen. Packages contained wasabi soybeans. The top label on the lid stated Wasabi Soybeans, however the ingredient label on the bottom of the container was for Wasabi Peas which does not include Wheat and Soy allergens ingredients.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1467-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Giant Eagle, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1467-2017.

Giant Eagle, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Giant Eagle, Inc. Recall FAQ

Giant Eagle, Inc. is the subject of a food safety report: Market District Wasabi Soybeans; Net Wt. 6 OZ.; Best By 3/6/17. The notice was published on September 29, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 432 units are potentially affected.